Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Molecular Cancer Research : MCR|June 29, 2017
BRAF-inhibitor Associated MEK Mutations Increase RAF-Dependent and -Independent Enzymatic ActivityCaroline M Emery, Kelli-Ann Monaco, Ping Wang, et al.
RNA (New York, N.Y.)|May 15, 2002
Development and characterization of a reconstituted yeast translation initiation systemMikkel A Algire, David Maag, Peter Savio, et al.
Biochemistry|April 1, 2016
Structural and Functional Consequences of Three Cancer-Associated Mutations of the Oncogenic Phosphatase SHP2Jonathan R LaRochelle, Michelle Fodor, Xiang Xu, et al.
Elife|March 23, 2021
Time-resolved phosphoproteomics reveals scaffolding and catalysis-responsive patterns of SHP2-dependent signalingVidyasiri Vemulapalli, Lily A Chylek, Alison Erickson, et al.
Oncotarget|November 17, 2018
The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer modelsSunkyu Kim, Ralph Tiedt, Alice Loo, et al.
Oncotarget|April 16, 2020
Correction: The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer modelsSunkyu Kim, Ralph Tiedt, Alice Loo, et al.
ACS Chemical Biology|January 6, 2018
Dual Allosteric Inhibition of SHP2 PhosphataseMichelle Fodor, Edmund Price, Ping Wang, et al.
Nature|July 1, 2016
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinasesYing-Nan P Chen, Matthew J LaMarche, Ho Man Chan, et al.
Pageof 3